Lerapolturev Active Not Recruiting Phase 2 Trials for Malignant Glioma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02986178PVSRIPO in Recurrent Malignant Glioma